Hematology Flashcards

1
Q

RBC

A

heme: iron is part of heme, binds/releases O2
globin: made of 4 subunits; in adult hgb (HgbA) there are 2 alpha chains and 2 beta chains

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Iron*

A

TRANSFERRIN: binds to free Fe to reduce oxidative damage assoc w/ free Fe - TRANSPORTS Fe throughout body

TIBC: indirect way to measure transferrin levels (total iron-binding capacity)

FERRITIN: most Fe not used for hgb synthesis is stored in ferritin protein molucule
-FERRITIN = FE STORES

SERUM FE: measures amount of Fe bound to transferrin

Labs Interpretation:

  • INC TRANSFERRIN + INC TIBC –> Iron Deficiency (more transferrin leads to dec transferrin saturation)
  • DEC TRANSFERRIN + DEC TIBC –> anemia of chronic disease; transferrin an acute phase reactant aimed at decreasing Fe available for microbes, may also be decreased in iron-overload states
  • DEC FERRITIN: Iron-deficiency anemia (pt w/ reduced Fe use up their stores first, decreased stored Fe)
  • INC FERRITIN: anemia of chronic disease (inc ferritin sequesters iron, reduce serum Fe levels available to bacteria)
  • DEC SERUM FE: seen w/ both Iron Deficiency anemia (dec total body Fe) and Anemia of Chronic Dz (lowering of serum Fe)
  • best way to distinguish btw Fe deficiency and anemia of chronic disease is by TIBC + Ferritin:
  • FE DEFICIENT ANEMIA: DEC SERUM FE, DEC FERRITIN, INC TIBC (use up stores –> dec ferritin, and inc bind capacity)

-ANEMIA OF CD: DEC SERUM FE, INC FERRITIN, DEC TIBC
(body makes more ferritin to pick up Fe from serum so not available for mo, binding capacity low bc most ferritins are occupied)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Fe-related Acute Phase Reactants / labs*

A

Responses meant as acute response but in chronic diseases, persist, and lead to anemia due to reduced serum Fe and decreased Fe availability for hgb production

  • DEC TRANSFERRIN + DEC TIBC –> anemia of chronic disease; transferrin an acute phase reactant aimed at decreasing Fe available for microbes, may also be decreased in iron-overload states
  • INC FERRITIN: anemia of chronic disease (inc ferritin sequesters iron, reduce serum Fe levels available to bacteria)
  • INC HAPTOGLOBIN: binds free hgb, reducing Fe available for mo
  • INC CRP: marker inflam/infx –> causes mo destruction by inc opsonization (marking cell for destruction by macros)
  • INC HEPCIDIN: prevents Fe release from macrophages, reducing Fe available for mo
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

hemolytic anemias - types

A

anemia caused by inc RBC destruction when rate of destruction exceeds BM ability to replace cells

Intrinsic (Inherited Disorders):

  • Sickle Cell
  • Thalassemia
  • G6PD deficiency
  • Hereditary spherocytosis

Extrinsic (Acquired Disorders):

  • Autoimm Hemolytic Anemia
  • DIC
  • TTP
  • HUS
  • Paroxysmal nocturnal hemoglobinuria
  • Hypersplenism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

hemolytic anemias - general findings

A

RETICULOCYTOSIS: BM release immature RBC

INC LDH: enzyme found in abundance in RBCs, inc RBC destruction leads to inc serum LDH

INC INDIRECT BILIRUBIN: inc RBC destruction overwhelms liver’s UGT enzyme conjugating ability, there will be inc indirect bili –> +/-JAUNDICE
-sometimes inc direct bilirubin –> dark urine

DEC HAPTOGLOBIN: inc RBC destruction leads to INC FREE HGB –> HAPTOGLOBIN BINDS to reduce oxidative toxicity; when haptoglobin used up, levels are low

+SHISTOCYTES ON PERIPHERAL SMEAR: fragmented RBC from destruction in spleen, liver or small BV (ex small BV thrombosis –> DIC, TTP, HUS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Anemia Basics

A

3 causes of anemia: increased blood loss, increased RBC destruction, decreased RBC production

  • sx-
  • CARDIO: palp, tachy, ortho/hypo, high output HF, syncope
  • PULM: SOB, tachy, chest pain
  • SKIN: pallor, pale conjunctiva, purpura, petechiae
  • NEURO: HA, neuropathies, AMS, vertigo
  • ABDOMEN: hepatosplenomegaly, ascites, +hemoccult bld
  • dx-
  • CBC w/ RBC indices: hgb, hct, MCV, MCH, RDW, RBC
  • peripheral blood smear; BM BX GOLD STANDARD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Anemia: Lab –> Morphologic Approach**

A
  1. RETIC COUNT
  • INC: brisk BM response to HEMOLYSIS OR BLOOD LOSS
  • -> BLOOD LOSS: tissue or occult loss
  • -> HEMOLYSIS: intrinsic/hereditary or extrinsic/acquired

-DEC: DEFICIENT RBC PRODUCTION (reduced BM response) –> LOOK AT MCV

–> MICROCYTIC (<80): IRON DEFICIENT, LEAD, THALASSEMIA, EARLY Anemia Chronic Dz

–> NORMOCYTIC (80-100): ANEMIA CHRONIC DZ, renal, mixed, endocrine, dilutional, early Fe deficiency

–>MACROCYTIC (>100): B12, FOLATE, liver dz, etoh, hypothyroidism; myelodysplastic syndrome, acute leukemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

B12 (cobalamin) Deficiency**

A
  • stomach acids release B12 from food + binds to IF for absorption in TERMINAL ILEUM
  • B12 deficiency causes ABNORMAL SYNTHESIS OF DNA, nucleic acid and abnormal metabolism of erythroid precursors
  • etiologies:
  • PERNICIOUS ANEMIA: AUTOIMM DESTRUCTION/LOSS OF GASTRIC PARIETAL CELLS that secrete IF
  • Vegans
  • MALABSORPTION: ETOHism, diseases affecting ileum
  • Dec IF production: acid-reducing drugs, gastric sx, atrophic gastritis
  • sx- NEURO SX: PARESTHESIAS, GAIT ABNORMAL, MEMORY LOSS, DEMENTIA
  • GI: anorexia, D, glossitis, anemia
  • dx-
  • labs: INC MCV (>115), HYPERSEGMENTED NEUTROPHILS, inc homocysteine, inc methylmalonic acid, dec B12 levels
  • PERNICIOUS ANEMIA: +IF antibodies, parietal cell Ab, inc gastrin level, +SHILLING TEST

-tx- IM or subQ B12 to start –> WATCH FOR SIGNS OF HYPO-K (replacement leads to retics w/ new cells taking up lots of potassium)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Folate (Vitamin B9) Deficiency*

A
  • folate absorption occurs in jejunum; stores last ~4 mo
  • folate required for DNA synthesis
  • etiologies: malabsorption, pregnancy, hemolysis (inc cell turnover), meds (methotrexate, bactrim, phenytoin)
  • sx- similar to B12 but no neurological abnormalities, GLOSSITIS
  • dx- INC MCV (>115), HYPERSEGMENTED NEUTROPHILS
  • dec folate, normal B12, inc serum homocysteine only
  • tx- FOLIC ACID 1 MG PO DAILY
  • replacing folate if it is B12 deficiency will correct anemia but neuro sx will worsen*
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

general causes for microcytic anemia

A
  • dec iron availability (Fe deficiency, anemia CD, copper dz)
  • dec heme production (lead poison, sideroblastic anemia)
  • dec globin production (thalassemia, hgb-opathies)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Iron Deficiency Anemia**

A

Etiologies:

  • CHRONIC BLOOD LOSS: excessive periods, occult (colon ca, parasitic hookworms)
  • dietary deficiency/inc requirements: pregnancy, rapid growth, infants breastfed

-sx- PAGOPHAGIA (ICE CRAVE), PICA, ANGULAR CHEILITIS, KOILONYCHIA (nail spooning)

  • dx- DEC FERRITIN, INC TIBC, DEC SERUM FE
  • INC RDW (dec RBC count/hgb/hct +/- dec MCV)
  • DEC TRANSFERRIN SATURATION, dec reticulocytes
  • tx- IRON REPLACE
  • Ferrous sulfate 325 mg PO daily, best on empty stomach; Vit C increases absorption
  • replace assoc w/ SE: N/V/C, cramps - start low and inc
  • SUPPLEMENT –> INC RETIC COUNT WITHIN 7 DAYS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Lead Poisoning Anemia*

A
  • lead poisoning causes cell death, shortens lifespan of RBCs and inhibits multiple enzymes needed for heme synthesis –> ACQUIRED SIDEROBLASTIC ANEMIA
  • sx- ABD PAIN W/ CONSTIPATION, NEUROLOGIC SX (ataxia, fatigue, learning disabilities, coma, shock), anemia sx, metabolic acidosis +/- asymptomatic
  • dx-
  • INC SERUM LEAD + INC SERUM FE; dec TIBC, inc ferritin (looks like anemia cd but serum fe increased)
  • Peripheral Smear: MICROCYTIC, HYPOCHROMIC ANEMIA W/ BASOPHILIC STIPPLING (dots of denatured RNA)
  • RINGED SIDEROBLASTS in BM (iron accum in mitoch)
  • xray: LEAD LINES (linear hyperdensities at metaphyseal plates, LEAD LINES IN GUMS OF ADULTS
  • tx- remove source of lead; CHELATION TX IF SEVERE
  • Treatment is oral succimer or IV EDTA (calcium disodium edetate, given after dimercaprol)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

thalassemia overview*

A
  • decreased production of globin chains
  • GENETIC BENEFIT AGAINST MALARIA

Normal: after 6 mo old, adult Hgb is predominant

  • HgbA (adult): 2 alphas, 2 betas - 95%
  • HgbA2: 2 alphas, 2 deltas - 1.5-3%
  • HgbF (fetal): 2 alphas, 2 gammas - trace

-THINK THALASSEMIA IF MICROCYTIC ANEMIA W/ NORMAL OR INC SERUM FE OR NO RESPONSE TO INC IRON

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

alpha thalassemia*

A

Decreased alpha-globin chain production; 4 genes determine it
-mc SE asians

  • Silent Carrier: 1/4 genes - clinically normal
  • Alpha Thal Minor/Trait: 2/4 - mild microcytic anemia
  • Alpha Thal Intermediate (Hgb H Dz): 3/4 - chronic anemia, pallow, hepatosplenomegaly, frontal maxilla bony overgrowth, frx, pigmented gallstones, iron overload
  • Hydrops Fetalis: 4/4 - stillbirth or death shortly after –> Barts Hgb (4 gamma-globins)
  • dx-
  • CBC: hypochrom, microcytic (60-75 - smaller than Fe def)
  • normal or inc RBC count, normal or inc serum Fe/stores
  • Hgb may be as low as 3-6
  • Periph Smear: TARGET CELLS, teardrop cells, basophilic stippling
  • HEINZ BODIES IN HGB H DISEASE (insoluble B-chain x4)
  • HgB Electrophoresis

-tx-
-mild (a-trait) - no tx needed
-moderate: folate (if retic count high), avoid Fe supplement
-severe: blood transfusions weekly, vit c, folate supplement
Iron-chelating agents (prevents Fe overload), +/-splenectomy
-allogeneic BM transplant is the definitive tx of major

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

beta thalassemia*

A

Decreased production of beta-globulin chains –> excess a-chains
-MC IN MEDITERRANEAN, AFRICANS

-Trait (minor): 1/2 abn alleles - usually asymptomatic, +/- mild to mod anemia (50% decrease in B synthesis)

  • Intermedia: mild homozygous form - milder sx than major
  • -> hepatosplenomegaly, anemia, bony disease

-Major (Cooley’s anemia): 2/2 abn alleles - usually asymptomatic at birth (bc of hgbF) but BECOME SYMPTOMATIC AT 6 MONTHS –> ineffective erythropoiesis, erythroid hyperplasia, FRONTAL BOSSING + MAXILLARY OVERGROWTH, HEPATOSPLENOMEGALY, SEVERE HEMOLYTIC ANEMIA, osteopenia, Fe overload, pigmented gallstones

  • dx-
  • Electrophoresis:
  • Trait/Minor: Inc HgbF, Inc HgbA2, Dec HgbA (dec B chain)
  • Cooleys/Major: Inc HgbF (up to 90%), inc HgbA2, little to no HgbA

Skull X-rays: bossing w/ “hair on end appearance” due to extramedullary hematopoiesis

  • tx- MAJOR
  • periodic blood transfusions, Vit C, folate supplementation, avoid excess Fe intake
  • Iron-chelating agents: IV Deferoxamine, PO Deferasirox
  • Splenectomy if refractory
  • Allogenic BM transplant definitive
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

anemia of chronic disease

A

Normocytic
Infx, inflammation, auto immune, malignancy → decreased RBC production vs. increased loss

  • Primary mechanism is decreased RBC production
  • Decreased serum Fe to prevent availability to pathogens
  • Lactoferrin from macrophages binds Fe better than transferrin and may shunt iron away from RBCs
  • Hepcidin: produced by liver; inhibits macrophage Fe release
  • Increased ferritin –> sequesters iron in storage

-dx-
↓ serum iron, TIBC, ↑ (or normal) ferritin
-GOLD STD: BM Fe STORE STUDY

-tx-
Tx underlying disease, supportive care
Erythropoietin-A if renal disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency*

A

G6PD is protective enzyme to RBC against oxidative stress –> w/out it, oxidative stress oxidizes Hgb into methemoglobin (doesn’t carry O2 well) –> inc RBC membrane damage/fragility and denatured Hgb –> DENATURED HGB PRECIPITATES AS HEINZ BODIES which target them for destruction by spleen –> EPISODIC HEMOLYTIC ANEMIA
-Sex-linked; MC males and AA

-Stressors: INFX MC, FAVA BEANS, SULFA DRUGS, ANTIMALARIALS, fluoroquinolones, nitrofurantoin, asa, mothballs

  • sx- EPISODIC ACUTE HEMOLYTIC ANEMIA
  • back or abd pain, jaundice, SPLENOMEGALY
  • splenic RBC sequestration –> HEMOLYTIC CRISIS
  • dx-
  • peripheral smear: in crisis, NORMOCYTIC HEMOLYTIC ANEMIA: SCHISTOCYTES, +- HEINZ BODIES
  • labs: inc retic, inc indirect bili, dec haptoglobin, G6PD ENZYME ASSAY

Tx: stop offending agents, hydrate, no more drug
-severe anemia: Iron/Folic acid supplement +/- blood trans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

sickle cell disease**

A
  • Sickle Cell Disease: auto-recessive disorder of HgbSS –> valine subs for glutamic acid on the beta chain (point mutation), 0.15% of AA
  • Sickle Cell Trait: HETEROZYGOUS HgbS (AS) –> 8% of AA, confers some resistance to malaria (plasmodium falciparum); usually asymptomatic unless exposed to severe hypoxia/dehydration, MAY HAVE EPISODIC HEMATURIA AND INABILITY TO CONCENTRATE URINE
  • patho- dec solubility of Hgb S under hypoxic conditions –> RBC sickling causes micro thrombosis and hemolytic anemia (sickled cells destroyed by spleen)
  • sx-
  • BEGIN @ 6 MO; DACTYLITIS MC 1ST SX (swelling of digits)
  • INF: OSTEOMYELITIS (ESP SALMONELLA), FUNCTIONAL ASPLENIA, APLASTIC CRISIS ASSOC W/ PARVO B19, folate deficiency
  • Hemolytic anemia: gallstones, jaundice
  • MICROTHROMBOSIS (INFARCTS):
  • Skeletal: H-SHAPED VERTEBRAE, ischemic necros of bones (like femoral and humeral head)
  • SPLENIC SEQUESTRATION CRISIS –> acute splenomegaly and rapidly dec Hgb –> SPLENIC INFACT (FX ASPLENIA)
  • SKIN ULCERS esp on tibia
  • PAINFUL OCCLUSIVE CRISES: triggered by cold, hypoxia, infx, dehydration, ETOH, pregnancy, ABRUPT PAIN, renal or hepatic dysfx, PRIAPISM
  • dx-
  • CBC: dec Hgb, dec Hct, inc retic
  • Smear: target cells, sickled cells, +HOWELL-JOLLY BODIES (indicates fx asplenia)
  • ELECTROPHORESIS: GOLD STANDARD
    • Disease: HgbS, no HgbA, inc HgbF
    • Trait: HgbS, dec HgbA

-tx-
-IV HYDRATION AND O2 FIRST STEP IN PAIN CRISIS (reverses/prevents sickling)
-NARCOTICS for pain, avoid meperidine
+/-RBC TRANSFUSION IN SEVERE

  • HYDROXYUREA - reduces freq of pain crisis (inc RBC water, dec RBC sickling, inc HgbF - resistant to sickling)
  • FOLIC ACID - needed for RBC production and DNA synth
  • CHILDREN IMMUNIZE FOR S.PNEUMOCOCCUS, Hib, N.MENINGOCOCCUS
  • CHILDREN: PROPHYLACTIC PCN UNTIL 6 YO
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

hereditary spherocytosis (HS)*

A

Autosomal dominant - intrinsic hemolytic anemia

  • RBC MEMBRANE/CYTOSKELETON DEFECT –> INC CELL FRAGILITY AND SPHERE-SHAPED RBCs –> INC RBC HEMOLYSIS BY SPLEEN
  • aplastic crisis if infected w/ ParvoB19
  • sx-
  • hemolysis: anemia, jaundice, SPLENOMEGALY, pigmented black gallastones

-dx-
-Smear: HYPERCHROMIC MICROCYTOSIS (80% SPHEROCYTES)
+OSMOTIC FRAGILITY TEST, COOMBS NEGATIVE

  • tx-
  • FOLIC ACID (not curative but helpful - maintains RBC production and DNA synthesis)
  • SPLENECTOMY TX OF CHOICE IN SEV DISEASE
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

autoimmune hemolytic anemia (AIHA)*

A

AB ON RBC’s OWN SURFACE –> inc destruction by macrophages and spleen
-IDIOPATHIC MC, meds +/- warm or cold

-Warm Agglutinins: IgG Ab causes splenic macrophage RBC destruction via phagocytosis @ core body temp –> autoimmune (SLE, RA), malignancy (CLL)

  • Cold Agglutinins: IgM Ab vs. RBC induces intravascular complement-mediated RBC lysis, esp at cold temps - may follow infx (MYCOPLASMA, EBV, HIV), malignancy
  • anemia, ACROCYANOSIS, fatigue, dyspnea, +/-Raynauds

-dx-
+DIRECT COOMBS TEST (separates from hereditary type)
-Smear: MICROSPHEROCYTES, polychromasia, RBC agglutination

  • tx-
  • WARM: CORTICO 1ST LINE –> splenectomy or Rituximab
  • COLD: AVOID COLD EXPOSURE –> +/- Rituximab
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

paroxysmal nocturnal hemoglobinuria*

A

RARE, ACQUIRED STEM CELL MUTATION –> RBCs deficient in GPI anchor surface protein that protects RBC from complement –> INC COMPLEMENT-MEDIATED RBC DESTRUCTION AND THROMBOSIS

  • sx-
  • HEMOLYTIC ANEMIA - DARK COLA URINE during night or early am w/ clearing during the day
  • VENOUS THROMBOSIS OF LARGE VESSELS - free Hgb binds w/ nitric oxide, decreased NO levels lead to hypercoag state –> thrombosis in uncommon veins
  • PANCYTOPENIA - protein deficiency in RBC, WBC, platelets –> bone marrow failure
  • dx-
  • FLOW CYTOMETRY BEST SCREEN
  • osmotic fragility test, Coombs Neg
  • may progress into myelodysplasia and AML
  • tx-
  • ECULIZUMAB (anti-complement C5 ab)
  • Prednisone dec hemolysis; BM transplant
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

primary hemostasis

A

PLATELETS form plug at site of vascular injury –> PLATELET ADHESION, ACTIVATION (send out ADP + thromboxane A2 which attracts other platelets) AND AGGREGATION (forming a plug)

  • dz examples: thrombocytopenia (ITP, TTP, HUS, DIC, vWD)
  • DISORDERS THAT AFFECT PLATELETS WILL AFFECT PRIMARY HEMOSTASIS, bleeding time;
  • PT + PTT USUALLY UNAFFECTED

-sx- PETECHIAE + MUCOCUTANEOUS BLEEDING

23
Q

secondary hemostasis

A

CLOTTING FACTORS respond in cascade to form FIBRIN STRANDS THAT STRENGTHEN THE PLATELET PLUG (from primary hemostasis)

  • dz examples: hemophilia, DIC, vWD
  • disorders affecting the EXTRINSIC PATHWAY –> PROLONGS PT and affecting the INTRINSIC PATHWAY –> PROLONGS PTT

-sx- DEEP DELAYED BLEEDING (HEMARTHROSIS) + DELAYED BLEEDING AFTER SURGERY

24
Q

extrinsic vs intrinsic pathway

A

Extrinsic: activated OUTSIDE the BV; Factor 7 leaves open BV and comes in contact w/ tissue factor (TF)
-prolonged PT

Intrinsic : damage to surface “within” BV activates intrinsic
-prolonged PTT

25
Q

PTT (partial thromboplastin time)*

A

measures efficacy of INTRINSIC and common coag pathway

  • normal PTT time requires Factors 1, 2, 5, –> 8, 9, 11, 12!
  • PROLONGED: HEPARIN, DIC, vWD, HEMOPHILIA A/B
26
Q

PT (prothrombin time)*

A

measures EXTRINSIC (tissue factor) pathway and common pathway

  • normal PT times require Factors 1, 2, 5 –> 7 + 10!
  • PROLONGED: WARFARIN TX, VITAMIN K DEFICIENCY, DIC
27
Q

thrombotic thrombocytopenic purpura (TTP)*

A
Dec ADAMTS13 (a vWF cleaving protease) --> large vWF adhere to platelets and causes endothelial platelet adhesion --> SMALL VESSEL THROBOSIS --> damage/shear the RBC (HEMOLYTIC ANEMIA)
-MC FEMALE
  • Primary TTP: IDIOPATHIC –> Ab vs. ADAMTS13
  • Secondary TTP: malignancy, BM transplant, SLE, estrogen, pregnancy, HIV
  • sx- Pentad:
  • THROMBOCYTOPENIA (petechiae, bruising, mucocutaneous bleeding - skin, oral, epistaxis, GI/GU)
  • MICROANGIOPATHIC HEMOLYTIC ANEMIA (anemia, jaundice, fragmented rbc/schistocytes on smear)
  • KIDNEY FAILURE/UREMIA (not as common)
  • NEURO SX (HA, CVA, AMS)
  • FEVER (rare)
  • dx-
  • labs: THROMBOCYTOPENIA, NORMAL PT/PTT
  • hemolytic anemia –> Smear: inc retics, schistocytes
  • SPLENOMEGALY

-tx-
-PLASMAPHERESIS TX OF CHOICE
-IMMUNOSUPPRESION - CORTICOSTEROIDS
-no platelet transfusions (may cause thrombi formation)
+/- splenectomy if refractory

28
Q

hemolytic uremic syndrome*

A

PLATELET ACTIVATION BY EXOTOXINS
-toxins from infx –> damage vascular endothelium & activates platelets (microthrombi) –> platelets get depleted –> thrombocytopenia
(toxins preferentially damage kidney, small vessel thrombosis cause RBC damage as they circulate/shear = hemolytic anemia)

  • MC W/ CHILDREN; usually preceded by ENTEROHEMORRHAGIC E.COLI 0157, SHIGELLA OR SALMONELLA *suspect in children w/ renal failure w/ diarrhea prodrome
  • adults: seen w/ HIV, SLE, antiphospholipid synd
  • sx- Triad:
  • THROMBOCYTOPENIA (petechiae, bruising, purpura)
  • MICROANGIOPATHIC HEMOLYTIC ANEMIA (anemia, jaundice, fragmented rbc/schistocytes on smear)
  • KIDNEY FAILURE/UREMIA (MORE COMMON THAN TTP)
  • lacks fever and neuro sx seen in TTP but labs similar
  • dx- INC BUN/CREATININE and…same as TTP
  • labs: THROMBOCYTOPENIA, NORMAL PT/PTT
  • hemolytic anemia –> Smear: inc retics, schistocytes
  • SPLENOMEGALY
  • tx-
  • OBSERVATION IN MOST (IV fluids for renal perfusion)
  • PLASMAPHERESIS +FFP if severe, or complications
  • ABX MAY WORSEN CONDITION (INC VEROTOXIN RELEASE BC OF CELL LYSIS)
29
Q

disseminated intravascular coagulation (DIC)*

A

PATHOLOGICAL ACTIVATION OF COAGULATION SYSTEM –> WIDESPREAD MICROTHROMBI (consumes coag proteins) + platelets –> SEVERE THROMBOCYTOPENIA: DIFFUSE BLEEDING from skin, resp tract, GI tract

  • INFX: GRAM NEG SEPSIS MC
  • MALIGNANCIES - AML, lung or GI cancer, prostate ca
  • OBSTETRIC - preeclampsia, abruption, septic abortion
  • massive tissue injury (burns), liver dz, viral, aortic aneurysm
  • sx-
  • WIDESPREAD HEMORRHAGE –> VENIPUNCTURE SITES
  • THROMBOSIS - renal, hepatic, resp dysfx, GANGRENE
  • dx-
  • INC THROMBIN FORMATION: DEC FIBRINOGEN, INC PTT/PT/INR, SEV THROMBOCYTOPENIA
  • Smear: fragmented RBC/schistocytes
  • INC FIBRINOLYSIS = INC D-DIMER
  • tx-
  • treat underlying cause!
  • FFP IF SEVERE BLEEDING +/- platelet transfusion
  • thrombosis: +/- heparin in severe cases
30
Q

idiopathic (autoimmune) thrombocytopenic purpura (ITP)*

A

Acquired, abnormal ISOLATED THROMBOCYTOPENIA of idiopathic cause (primary)
-secondary: imm-mediated, assoc w/ SLE, HIV, HCV

  • acute: MC CHILDREN AFTER VIRUS
  • chronic: MC IN ADULTS (often recurs), F <40y, M >70y

Autoimmune Ab reaction vs platelets –> spleen destroys platelets (often after acute infection - virus)

  • sx- often asymptomatic, NO SPLENOMEGALY
  • INC MUCOCUTANEOUS BLEEDING: purpura, bruises, petechiae, epistaxis, menorrhagia, bleeding gums

-dx-
-ISOLATED THROMBOCYTOPENIA W/ NORMAL PT/PTT
(platelet disorder, not coagulation disorder)

  • tx- support/observe if >20K platelets and no bleed
  • children: OBSERVE –> IVIG
  • adults: CORTICOSTEROIDS –> IVIG –> splenectomy if refractory

*transfusion of platelets on if <20K to prevent spontaneous intracranial hemorrhage (only if bleeding after cortico + ivig)

31
Q

Hemophilia A (factor 8 deficiency)*

A

MC type hemophilia (80%)
X-linked recessive, MALES (female rare) or spont mutation
-first episode usually < 18yo

Lack of FACTOR 8 –> AFFECTS INTRINSIC PATHWAY –> failure to form hematomas

  • sx- (same as Hemo B)
  • HEMARTHROSIS (80%) +/- bleed in wt-bearing joints (mc ankle)
  • Excessive hemorrhage w/ trauma + surgery (incisional bleeding), nose bleeds, bruising, blood in stool/urine
  • less commonly present w/ purpura/petechiae (bc platelets are normal) or spontaneous hemorrhage
  • dx-
  • LOW FACTOR 8, PROLONGED PTT, normal platelets
  • tx-
  • FACTOR 8 INFUSION - to levels 25-100% prn
  • DESMOPRESSIN (DDAVP) - transiently increases Factor 8 and vWF release so may be used prior to procedures
32
Q

Hemophilia B (factor 9 deficiency) Christmas Disease*

A

X-linked recessive trait - MALES
Lack of FACTOR 9 –> AFFECTS INTRINSIC PATHWAY

  • sx- (same as Hemo A)
  • HEMARTHROSIS (80%) +/- bleed in wt-bearing joints
  • Excessive hemorrhage w/ trauma + surgery (incisional bleeding), nose bleeds, bruising, blood in stool/urine
  • less commonly present w/ purpura/petechiae (bc platelets are normal) or spontaneous hemorrhage
  • DEEP TISSUE BLEEDING
  • dx-
  • DEC FACTOR 9, PROLONGED PTT (BUT CORRECTS W/ MIXING STUDY)
  • tx-
  • FACTOR 9 INFUSION
  • DESMOPRESSIN NOT USEFUL!
  • -> MIXING STUDY
  • if affected blood is mixed w/normal plasma and PT/PTT corrects –> factor deficiency
  • IF DOESN’T CORRECT –> + PRESENCE OF FACTOR INHIBITORS (EX. LUPUS ANTICOAG, ANTIPHOSPHOLIPID SYNDROME)
33
Q

Von Willebrand Disease*

A

DEFICIENT/DEFECTIVE vWF –> INEFFECTIVE PLATELET ADHESION (aggregation normal)

  • vWF necessary for initial platelet adhesion and prevents Factor 8 degradation
  • autosomal dom disorder
  • MC HEREDITARY BLEEDING DISORDER (1% pop)
  • sx-
  • MUCOCUTANEOUS BLEEDING: easy bruising, epistaxis, gums, GI, periods; varing degrees
  • BLEED AFTER MINOR LACERATIONS > incisional bleed
  • PETECHIAE (rare in hemophilias)
  • dx-
  • DEC vWF LEVELS +/- PROLONGED PTT (dec Factor 8)
  • bleeding time and PTT worse w/ aspirin
  • stress, sx, pregnancy, OCP may inc vWF
  • DEC RISTOCETIN ACTIVITY TEST GOLD STANDARD (no platelet aggregation w/ ristocetin abx)
  • tx-
  • avoid aspirin, assess bleeding times before procedures
  • mild: no tx needed
  • mod: DESMOPRESSIN (DDAVP) inc vWF, Factor 8
  • sev: absent vWF –> supplement w/ vWF-containing products and Factor 8 (DDAVP NOT HELPFUL)
34
Q

hodgkin’s lymphoma*

A

Lymphocyte neoplasm

  • peaks @ 20yo and >50yo; MC in MALES
  • assoc w/ EBV
  • sx-
  • PAINLESS LYMPADENOPATHY - firm, nontender, mobile (esp upper body) ALCOHOL MAY INDUCE LYMPH NODE PAIN!
  • SYSTEMIC “B” SX: (advanced dz) PEL-EBSTEIN FEVER (cyclical fever 1-2 wks), NIGHT SWEATS, WT LOSS, anemia
  • dx-
  • EXCISIONAL BIOPSY –> REED-STERNBERG CELL PATHOGNOMONIC “OWL EYE” APPEARANCE
  • MEDIASTINAL LYMPHADENOPATHY - PET/CT scan to stg
  • tx-
  • local (stg 1,2,3a): radiation
  • stg 3b, 4: combo chemo
  • HODGKIN’S LYMPHOMA HIGHLY CURABLE COMPARED TO NON-HODGKINS
35
Q

non-hodgkin lymphoma*

A

Lymphocyte neoplasm: diffuse B cell, T cell, follicular

  • MC >50y; RF: INC AGE, IMMUNOSUPPRESSION
  • PERIPHERAL LYMPH NODES MC
  • sx-
  • PAINLESS LYMPHADENOPATHY –> EXTRANODAL SITES COMMON (GI, SKIN, CNS MC)
  • BURKITT LYMPHOMA - often presents w/ abd pain (sporadic), jaw involvement - histology “starry sky”
  • Systemic “B” sx: fever, night sweats, WL, anemia, pruritis rarer in NHL
  • dx- EXCISIONAL BX
  • PET/CT scan to stage
  • tx- UNPREDICTABLE COURSE
  • Follicular: indolent form (not usually curable) –> RITUXIMAB (AB vs CD20 on B cells)
  • Diffuse Large B Cell: MC and MOST AGGRESSIVE (but curable w/ chemo) R-CHOP
36
Q

waldenstrom macroglobulinemia

A

B-cell lymphoma –> PRODUCES EXCESS IgM

  • sx- often asymptomatic
  • ORGANOMEGALY:lymphadenopathy, hepatosplenomegaly
  • HYPERVISCOSITY SYNDROME (large IgM mol increase serum viscosity, slow blood through caps –> blurry vision, HA, vertigo, dizzy, diplopia, ataxia —> retinal hemorrhages
  • ANEMIA (bone marrow failure)
  • CHRONIC OOZING BLOOD FROM NOSE, GUMS (IgM interacts w/ platelets and inhibits fibrin formation)
  • peripheral neuropathy
  • CRYOGLOBULINEMIA - IgM precipitates out of serum in cold temps –> raynauds

-dx-
-SERUM PROTEIN ELECTROPHORESIS: IgM monoclonal spike (MM is IgG or IgA spike)
BM Biopsy: >10% lymphobplasmacytic infiltrate, DUTCHER BODIES

  • tx-
  • Responsive to chemo but rarely curative; CHOP may be used
  • Rituximab may be used alone if mild sx
  • PLASMAPHERESIS to treat severe hyperviscocity w/ comp
  • incurable but treatable - med survival rate 5 years
37
Q

monoclonal gammopathy of undetermined significance

A

INC IMMUNOGLOBULINS W/OUT CLINICAL SX/ORGAN DAMAGE

  • 1% adults; 3% >70yo - inc risk of devo MM or lymphoma
  • MC IgG (70%)
  • may be assoc w/ other dz, infx, auto imm

-sx- ASYMPTOMATIC BY DEFINITION

  • dx-
  • SERUM PROTEIN ELECTROPHORESIS: MONOCLONAL SPIKE (usually stable over time)
  • URINE PROTEIN ELECTROPHORESIS - none/stable amt bence-jones proteins
  • BM BIOPSY DEFINITIVE (<10% OF PLASMA CELLS)
  • absence of hyperCa, anemia, renal failure, lytic bone lesions (like MM)
  • tx-
  • CONSERVATIVE OR OBSERVATION - low malignant risk
38
Q

multiple myeloma (plasmacytoma)*

A

proliferation of SINGLE CLONE OF PLASMA CELLS –> INC MONOCLONAL AB (ESP IgG and IgA)
-RF: >65yo, AA, MEN

  • sx-
  • BONE PAIN: spine, ribs - due to OSTEOLYTIC LESIONS
  • RECURRENT INFX: strep pneumo, gram neg from LEUKOPENIA, hyperviscosity
  • HYPERCALCEMIA - bc of bone destruction
  • ANEMIA
  • KIDNEY FAILURE
  • dx-
  • Serum Electrophor: MONOCLONAL M SPIKE (IgG 60%)
  • Urine Electrophoresis: BENCE JONES PROTEINS
  • CBC: ROULEAUX FORMATION, inc ESR
  • xray: “PUNCHED OUT” LYTIC LESIONS
  • BM bx: PLASMACYTOSIS
  • tx-
  • AUTOLOGOUS STEM CELL TRANSPLANT DEFINITIVE
  • preceded by chemo
  • bisphosphonates for bony destruction
39
Q

acute lymphocytic leukemia (ALL)*

A

malignancy of lymphoid stem cells in BM –> lymph nodes, spleen, liver, other organs
-MC CHILDHOOD (peak 3-7yo); DOWN SYND >5yo

  • sx-
  • Pancytopenia sx: FEVER MC, fatigue, bone pain
  • CNS SX: ha, visual change, vomit
  • HEPATOSPLENOMEGALY, LYMPHADENOPATHY
  • petechiae, bruising
  • dx-
  • BM: HYPERCELLULAR W/ >20% BLASTS; WBC: 5-100K, thrombocytopenia

-tx-
-oral chemo; HIGHLY RESPONSIVE TO COMBO CHEMO
(remission >90%)
-stem cell transplant if relapse; METHOTREXATE FOR CNS DISEASE

40
Q

acute myelogenous leukemia (AML)*

A

-MC ACUTE FORM LEUKEMIA >50yo

-sx-
-PANCYTOPENIA, SPLENOMEGALY, GINGIVAL HYPERPLASIA
+/-LEUKOSTASIS (WBC >100K)

-dx-
>20% BLASTS (WBC)
-promyelocytic: +AUER RODS
-acute monocytic: gingival infiltration/hyperplasia
-MEGAKARYOCYTIC: INC IN DOWN SYNDROME
  • tx-
  • COMBO CHEMO, STEM CELL after remission
  • TUMOR LYSIS SYND: inc K, dec Ca, inc PHOS, hyperuricemia and renal failure –> ALLOPURINOL + FLUID
41
Q

chronic myelogenous leukemia (CML)*

A
  • well-differentiated WBC - granulocyte proliferation
  • OLDER MALES, >50y
  • sx-
  • asymptomatic until BLASTIC CRISIS (ACUTE), SPLENOMEGALY
  • dx-
  • PHILADELPHIA CHROM
  • WBC > 100K
  • chronic: <5% blasts
  • accelerated: 5-30% blasts
  • acute: >30% blasts
  • tx-
  • PO CHEMO, stem cell in servere/failed chemo
  • IMATINIB for PHILADELPHIA +
42
Q

chronic lymphocytic leukemia (CLL)*

A
  • B CELL CLONAL MALIGNANCY
  • MC LEUKEMIA IN ADULTS OVERALL
  • sx-
  • most asymptomatic (incidental finding of leukocytosis on routine labs)
  • FATIGUE MC, inc infx, lymphadenopathy, hepatosplenmeg
  • dx-
  • Peripheral Smear: SMUDGE CELLS (fragile B cells), WELL-DIFFERENTIATED LYMPHOCYTES
  • tx-
  • indolent: observe
  • SYMPTOMATIC OR PROGRESSIVE: CHEMO –> FLUDARABINE
  • stem cell transplant curative
  • ZAP-70+ –> poorer prognosis
43
Q

polycythemia vera (primary erythrocytosis)*

A

PRIMARY ERYTHROCYTOSIS = INC HCT W/OUT HYPOXIA

  • acquired myeloproliferative disorder w/ OVERPRODUCTION OF ALL 3 MYELOID CELL LINES (PRIMARILY RBC, but also WBC and platelets)
  • lymphocytes normal
  • MC MEN, PEAK 50-60y, caused by JAK2 MUTATION
  • sx-
  • DUE TO INC RBC: HYPERVISCOSITY OR THROMBOSIS
  • ha, dizzy, tinnitus, blurred vision, PRURITUS ESP AFTER HOT BATH, fatigue
  • ERYTHROMELALGIA: episodic burn/throb of hands/feet w/ edema
  • SPLENOMEGALY, FACIAL FLUSH, engorged retinal veins
  • SPENT PHASE: marrow fibrosis w/ marked pancytopenia
  • dx- all 3 major OR 1st 2 major + minor
  • MAJOR: INC RBC MASS (HGB/HCT), HYPERCELLULAR ON BM BX, JAK2 MUTATION
  • MINOR: DEC SERUM ERYTHROPOIETIN LEVELS
  • NORMAL O2 SAT, inc wbc, platelets, iron deficiency
  • tx-
  • PHLEBOTOMY MANAGEMENT OF CHOICE (until hct <45), low dose ASA
  • myelosuppresion: HYDROXYUREA
  • allopurinol if pt hyperuricemic
  • Ruxolitinib is a JAK inhibitor
44
Q

secondary erythrocytosis*

A

major cause of inc RBC mass; MC obese, hx of smoking

  • 3 major causes:
  • Reactive MC type: HYPOXIA, PULM DISEASE (COPD), high altitude, smokers
  • Pathologic: no underlying tissue hypoxia (renal dz –> Ca), fibroids, hepatoma
  • Relative Polycythemia: normal RBC mass in setting of dec plasma volume, dehydration
  • sx-
  • sx of underlying cause, cyanosis, clubbing, HTN, hepatosplenomegaly, +/- heart murmur

-dx-
-INC RBC/HCT W/ NORMAL WBC + PLATELETS –> distinguishes from polycythemia vera (1ry)
normal EPO levels

-tx- underlying disorder, smoking cessation

45
Q

hereditary hemochromatosis

A

EXCESS IRON DEPOSITION IN PARENCHYMAL CELLS OF HEART, LIVER, PANCREAS, ENDOCRINE ORGANS

  • auto recessive disorder of inc iron storage and inc iron absorption
  • Men MC, C282Y HFE GENOTYPE

-inc intestinal Fe absorption –> inc serum Fe and inc deposition into organs/glands; sx due to organ dysfx

  • sx-
  • may be asymptomatic in early stage, usually begin >40y
  • Liver: abd pain, CIRRHOSIS, fatigue, megaly, arthralgia
  • HF: CARDIOMYOPATHY, ARRHYTHMIAS, failure
  • Hypogonadism: teste atrophy and impotence
  • Pancreas: beta cell damage –> DM
  • METALLIC OR BRONZE SKIN –> “BRONZE DIABETES”

-dx-
-INC SERUM IRON (>200), INC TRANSFERRIN SAT, INC FERRITIN, dec TIBC (similar to lead poisoning)
+/- inc LFTs, genetic test for HFE gene, inc risk liver ca
-LIVER BIOPSY GOLD STANDARD –> INC HEMOSIDERIN

  • tx-
  • PHLEBOTOMY WEEKLY until depletion of iron –> maintenance 3-4x year for life
  • Chelating agents if unable to do phlebotomy (anemia)
  • Tx complications, test relatives, genetic counsel
  • NO ETOH or VIT C
46
Q

coagulopathy of advanced liver disease

A

ADVANCED LIVER DISEASE ASSOC W/ DECREASED PRODUCTION OF COAG FACTORS
-liver makes all except 8 and vWF

-etio: cirrhosis, ESLD, ETOH, hemochromatosis, hepatitis, ischemia

  • sx-
  • BLEEDING is the classic finding, esp GI
  • portal HTN –> splenomegaly –> thrombocytopenia
  • malabsorption of Vit K
  • dx-
  • INC PT (inc ptt as disease advances), corrects w/ mixing
  • LOW ALBUMIN
  • no response to vitamin K
  • P. Smear: +/-TARGET CELLS
  • tx-
  • FRESH FROZEN PLASMA w/ active bleeding or invasive procedure (to replace coag factors); vit K won’t correct
  • Cryoprecipitate if low fibrinogen
47
Q

factor 5 leiden mutation*

A

MC INHERITED CAUSE OF HYPERCOAGULABILITY (5%)

-mutated factor V RESISTANT to breakdown by activated PROTEIN C –> HYPERCOAGULABILITY –> INC DVT AND PE ESP IN YOUNG PATIENTS

  • dx-
  • activated protein C resistance assay; if pos, confirm w/ DNA test
  • normal PT/PTT
  • hepatic vein thrombosis; not assoc w/ inc MI or CVA
  • tx-
  • high risk –> indefinite anticoag (may need thromboprophylaxis during pregnancy to prevent miscarriages)
  • mod risk –> prophylaxis during high-risk procedures
48
Q

protein C deficiency

A

autosomal dominant - hypercoagulable disorder

  • PROTEIN C A VIT-K DEPENDENT ANTICOAG, made by liver, and stimulates fibrinolysis and clot lysis (inactivates factor 5 + 8)
  • increased risk of recurrent DVT and PE
  • sx-
  • RECURRENT DVT OR PULMONARY EMBOLI, +/- fam hx, 70% of clots spontaneous

-tx-
-Heparin –> PO ANTICOAG FOR LIFE
(may devo WARFARIN-INDUCED SKIN NECROSIS)

49
Q

antithrombin III deficiency

A

hypercoagulable disorder:

  • inherited: auto dom
  • acquired: liver dz, nephrotic syndrome, DIC, chemo
  • antithrombin III inactivates surplus throbin; activity potentiated by heparin
  • ANTITHROMBIN III DEF RESULTS IN VENOUS THROMBOSIS
  • sx-
  • RECURRENT DVT OR PE (1st episode btw 20-30y)
  • tx-
  • asymptomatic: treat w/ anticoag before surgical proc
  • w/ thrombotic event –> HIGH DOSE IV HEPARIN then oral anticoag indefinitely
50
Q

DVT*

A

Patient with a history of smoking, long-distance travel, surgery, oral contraceptives use
Complaining of unilateral leg edema, leg pain, tenderness, and warmth
Physical exam may show a positive Homan sign
Diagnosis is made by ultrasound; Gold standard is venography
Most commonly caused by stasis, hypercoagulable state, trauma (Virchow triad)
Treatment is anticoagulation
Warfarin is contraindicated in pregnancy
Comments: Risk stratification by Wells criteria

51
Q

Methemoglobinemia*

A

Fe3+ → Hb can’t bind O2
Leftward shift of oxyhemoglobin dissociation curve
Causes: dapsone, nitrates, antimalarials, “-aines” (benzocaine)

sx:
SOB + clear lungs on PE + normal CXR
Cyanosis
Brown blood
Pulse ox in high 80s, will not respond to O2

dx: Co-oximetry

Tx: Methylene blue

52
Q

Heparin-Induced Thrombocytopenia (HIT)*

A

Patient with a history of recently starting heparin
Labs will show a 50% decrease in platelets
Treatment is to stop heparin, use direct thrombin inhibitor
Type 1: PLT recovery with or without heparin cessation
Type 2: autoimmune, venous/arterial thromboses

53
Q

fanconi anemia*

A

most common form of inherited aplastic anemia
PE will show absent or hypoplastic thumb, short stature, low set ears, deafness, strabismus, skin hyper- or hypopigmentation, cafe-au-lait spots, renal abnormalities
Labs will show macrocytic anemia and elevated fetal hemoglobin (HgF)
Most commonly caused by autosomal recessive defect in DNA repair
Treatment is bone marrow transplant
Comments: Most common form of inherited aplastic anemia. Increased risk for AML, solid tumors and aplastic anemia

54
Q

Antiphospholipid Antibody Syndrome*

A

Patient with a history of lupus or other rheumatic diseases
Complaining of repeated spontaneous abortions
Labs will show thrombocytopenia
Most commonly caused by autoimmune
Treatment is anti-coagulation